https://www.selleckchem.com/pr....oducts/crenolanib-cp
1 ± 1.3 mm² [P.001]; -2.1 ± 1.0 mm² [P.01]; -2.1 ± 1.4 mm² [P=.03], respectively) and in ostial distal MV and ostial SB after Axxess (-2.1 ± 0.8 mm² [P.001]; -1.6 ± 0.7 mm² [P.01], respectively), while in proximal Axxess segment, the MLA remained stable (-0.1 ± 0.0; P=.93) and significantly larger than modified-T, mainly due to a smaller neointimal area (1.8 ± 0.7 mm² vs 3.2 ± 0.6 mm²; P.001). Acute BVS strut discontinuities were observed in 53%, and late intraluminal dismantling was seen in 38% of patie
Like
Comment
Share
